RSR13 FDA Approval Status
FDA Approved: No
Brand name: RSR13
Generic name: efaproxiral
Company: Allos Therapeutics, Inc.
Treatment for: Brain Metastases in patients with Breast Cancer
Development Timeline for RSR13
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.